Assignee
XENON PHARMACEUTICALS INC
CA·62 granted patents·43 pending applications·500 citations·filing 2001–2025
Top patents by PatentIndex Score
105 records- 0196US10815229B1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Oct 27, 2020·4 cites·29 claims
- 0295US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0395US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0495US7511018B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2005·Granted Mar 31, 2009·27 cites·18 claims
- 0594US8030488B2Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Oct 4, 2011·34 cites·28 claims
- 0693US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0792US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 0892US7935721B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Granted May 3, 2011·18 cites·15 claims
- 0992US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 1092US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 1192US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 1291US11091441B2Solid state crystalline forms of a selective potassium channel modulatorXENON PHARMACEUTICALS INC·Filed 2020·Granted Aug 17, 2021·4 cites·62 claims
- 1391US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 1491US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 1590US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 1690US7390813B1Pyridylpiperazines and aminonicotinamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2002·Granted Jun 24, 2008·35 cites·8 claims
- 1789US10745392B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·4 cites·47 claims
- 1888US9481677B2Biaryl ether sulfonamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Nov 1, 2016·17 cites·17 claims
- 1988US7777036B2Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·13 cites·9 claims
- 2087US11957675B2Methods and uses for treating anhedoniaXENON PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·1 cites·36 claims
- 2187US11135214B2Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel openerXENON PHARMACEUTICALS INC·Filed 2019·Granted Oct 5, 2021·3 cites·26 claims
- 2287US9630929B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·11 cites·29 claims
- 2386US7893206B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2009·Granted Feb 22, 2011·5 cites·17 claims
- 2486US7514436B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Apr 7, 2009·22 cites·30 claims
- 2586US7456180B2Piperazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·24 cites·25 claims
- 2686US2024316033A1Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel openerXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2785US9480677B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·5 cites·1 claims
- 2885US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 2983US11325902B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·1 cites·33 claims
- 3082US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 3182US9695185B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·3 cites·1 claims
- 3282US9487535B2Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Nov 8, 2016·5 cites·26 claims
- 3382US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 3482US2025221980A1Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel openerXENON PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3580US12171759B1Methods and uses for treating anhedoniaXENON PHARMACEUTICALS INC·Filed 2024·Granted Dec 24, 2024·0 cites·27 claims
- 3679US12319657B1Solid state crystalline forms of a selective potassium channel modulatorXENON PHARMACEUTICALS INC·Filed 2025·Granted Jun 3, 2025·0 cites·30 claims
- 3779US10513526B2Solid state forms of spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2018·Granted Dec 24, 2019·2 cites·11 claims
- 3879US9260446B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·4 cites·5 claims
- 3978US10118932B2Solid state forms of spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2017·Granted Nov 6, 2018·2 cites·11 claims
- 4078US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 4177US2022062266A1Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel openerXENON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4276US2024408075A1Conjoint therapy for treating seizure disordersXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4375US10752623B2Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitorsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·1 cites·38 claims
- 4475US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 4575US2025275957A1Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel openerXENON PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4675US2024342156A1Methods for treating painXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4775US2025186426A1Methods and uses for treating anhedoniaXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4875US2024279182A1Solid state crystalline forms of a selective potassium channel modulatorXENON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4974US7816075B2Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Oct 19, 2010·1 cites·7 claims
- 5074US7785886B2Methods and reagents for modulating cholesterol levelsXENON PHARMACEUTICALS INC·Filed 2004·Granted Aug 31, 2010·5 cites·5 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when XENON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →